Viewing Study NCT05059106


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2025-12-31 @ 5:19 PM
Study NCT ID: NCT05059106
Status: UNKNOWN
Last Update Posted: 2021-09-28
First Post: 2021-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19
Sponsor: Federal University of Espirito Santo
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-06-01
Start Date Type: ACTUAL
Primary Completion Date: 2022-06-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2022-10-30
Completion Date Type: ESTIMATED
First Submit Date: 2021-09-24
First Submit QC Date: None
Study First Post Date: 2021-09-28
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-09-24
Last Update Post Date: 2021-09-28
Last Update Post Date Type: ACTUAL